- Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake. Garin, E., Devillers, A., Le Cloirec, J., Bernard, A.M., Lescouarc'h, J., Herry, J.Y., Reubi, J.C., Bourguet, P. European journal of nuclear medicine. (1998)